Singapore markets closed

Aadi Bioscience, Inc. (AADI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.4600-0.0700 (-4.58%)
As of 02:50PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 37.57M
Enterprise value -49.54M
Trailing P/E 1.89
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.73
Price/book (mrq)0.42
Enterprise value/revenue 3.48
Enterprise value/EBITDA -0.62

Trading information

Stock price history

Beta (5Y monthly) 0.31
52-week change 3-74.29%
S&P500 52-week change 322.23%
52-week high 37.2400
52-week low 31.2800
50-day moving average 31.6912
200-day moving average 32.5879

Share statistics

Avg vol (3-month) 3222.78k
Avg vol (10-day) 3158.76k
Shares outstanding 524.55M
Implied shares outstanding 624.55M
Float 816.05M
% held by insiders 110.81%
% held by institutions 154.15%
Shares short (28 Jun 2024) 4747.04k
Short ratio (28 Jun 2024) 42.52
Short % of float (28 Jun 2024) 44.50%
Short % of shares outstanding (28 Jun 2024) 43.04%
Shares short (prior month 31 May 2024) 4889.96k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 327 Aug 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -288.72%
Operating margin (ttm)-364.51%

Management effectiveness

Return on assets (ttm)-33.11%
Return on equity (ttm)-58.22%

Income statement

Revenue (ttm)23.84M
Revenue per share (ttm)0.88
Quarterly revenue growth (yoy)-8.80%
Gross profit (ttm)N/A
EBITDA -74.44M
Net income avi to common (ttm)-68.83M
Diluted EPS (ttm)-2.5500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)88.27M
Total cash per share (mrq)3.6
Total debt (mrq)1.16M
Total debt/equity (mrq)1.29%
Current ratio (mrq)5.16
Book value per share (mrq)3.68

Cash flow statement

Operating cash flow (ttm)-58.01M
Levered free cash flow (ttm)-35.58M